US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Progress

43.42

-0.9400-2.12%

Post-market: 43.34-0.0804-0.19%17:57 EDT

Volume:331.71K

Turnover:14.53M

Market Cap:1.78B

PE:20.97

High:44.99

Open:44.17

Low:43.38

Close:44.36

52wk High:47.37

52wk Low:23.82

Shares:41.01M

Float Shares:40.11M

Volume Ratio:0.89

T/O Rate:0.83%

Dividend:- -

Dividend Rate:- -

EPS(TTM):2.07

EPS(LYR):1.66

ROE:18.57%

ROA:4.89%

PB:3.52

PE(LYR):26.16

Loading ...

Overview Company News Filings

Press Release: BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress

Press Release: Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results

Matt Phipps Initiates Buy on Upstream Bio, Citing Favorable FDA Progress and Best-in-Class Potential for Verekitug

Analyst Reaffirms Buy on Shattuck Labs, Maintains $17 Price Target on TL1A Pipeline Progress

Sagimet Making 'Good Progress' in Bringing Denifanstat to US Patients, Wedbush Securities Says

MT Newswires Live

Akeso (SEHK:9926) Could Be 41% Undervalued On Phase II Breast Cancer Trial Progress

Simply Wall St.

Press Release: Veradermics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress

Upstream Bio Reports Second Quarter 2026 Financial Results and Highlights Continued Progress

Analyst Reiterates Buy on Vera as Trutakna Launch and IgAN Pipeline Progress Support Maintained $90 Price Target

Michael Matson Reiterates Buy on IMDX, Citing Regulatory Progress, GraftAssure Platform Expansion, and Solid Cash Runway Ahead of Expected 2026 De Novo Approval

Auvelity Momentum and Pipeline Progress Drive Undervalued Upside in Axsome, Supporting Buy Rating

European Midday Briefing: Oil Rises as Hormuz Talks Show Little Progress

Analyst Reiterates Buy on Warintza De-Risking Progress and Confirms $18 Price Target

Trump: CAP report on National Guard and crime is 'Radical Left SCAM'

Trump's Truth Social latest posts

DigitalX Updates Investors on Progress of On-Market Share Buy-Back

First Community Highlights Q2 2026 Growth and Integration Progress

Press Release: Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results

Jade Therapeutics: Buy Rating Reiterated as Strong Cash Position and Pipeline Progress Support Unchanged $42 Price Target

Buy Rating Reaffirmed on CNM-Au8 ALS Progress, Regulatory Momentum; $31 Price Target Maintained

Waton Financial Highlights AlphaSchema Research Progress in Structured AI-Assisted Trading Signal Discovery

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/PRGS/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PRGS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRGS\",,,,,undefined,":{"symbol":"PRGS","market":"US","secType":"STK","nameCN":"Progress","latestPrice":43.42,"timestamp":1787601600000,"preClose":44.36,"halted":0,"volume":331711,"hourTrading":{"tag":"盘后","latestPrice":43.3396,"preClose":43.42,"latestTime":"17:57 EDT","volume":18556,"amount":805701.0561,"timestamp":1787608676601,"change":-0.0804,"changeRate":-0.001852,"amplitude":0.001852},"delay":0,"changeRate":-0.021190261496843953,"floatShares":40109098,"shares":41012942,"eps":2.0704,"marketStatus":"Post-Mkt","change":-0.94,"latestTime":"08-24 18:13:08 EDT","open":44.17,"high":44.99,"low":43.38,"amount":14530923.109803,"amplitude":0.036294,"askPrice":43.78,"askSize":99,"bidPrice":43.14,"bidSize":99,"shortable":3,"etf":0,"ttmEps":2.0704,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":680760000000,"exchange":"NASDAQ","adjPreClose":44.36,"preHourTrading":{"tag":"盘前","latestPrice":43.4165,"preClose":44.36,"latestTime":"07:36 EDT","volume":1,"amount":43.4165,"timestamp":1787571404164,"change":-0.9435,"changeRate":-0.021269,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":43.3396,"preClose":43.42,"latestTime":"17:57 EDT","volume":18556,"amount":805701.0561,"timestamp":1787608676601,"change":-0.0804,"changeRate":-0.001852,"amplitude":0.001852},"volumeRatio":0.885287,"impliedVol":0.5223,"impliedVolPercentile":0.3108},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRGS\",,,,,undefined,":{"symbol":"PRGS","floatShares":40109098,"roa":"4.89%","roe":"18.57%","lyrEps":1.66,"volumeRatio":0.885287,"shares":41012942,"dividePrice":0,"high":44.99,"amplitude":0.036294,"preClose":44.36,"low":43.38,"week52Low":23.82,"pbRate":"3.52","psRate":"1.77","week52High":47.37,"institutionHeld":0.8478,"latestPrice":43.42,"eps":2.0704,"divideRate":0,"volume":331711,"delay":0,"ttmEps":2.0704,"open":44.17,"prevYearClose":42.96,"prevWeekClose":44.36,"prevMonthClose":40.59,"prevQuarterClose":33.58,"fiveDayClose":42.86,"twentyDayClose":38.66,"sixtyDayClose":30.54,"dividendPayoutRate":0.3319165239425613,"dividendFrequency":"Q","dividendGrowthYears":0,"dividendGrowthRate":-0.24999999999999992,"fiveYearAvgDividendRate":0.012866073843011212},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PRGS\",params:#limit:5,,,undefined,":[{"date":"2026-09-30","symbol":"PRGS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1790798400000,"name":null,"time":"Post-Mkt","dateTimestamp":1790740800000,"actualEps":null},{"market":"US","date":"2026-06-30","symbol":"PRGS","fiscalQuarterEnding":"2026/05","expectedEps":1.15,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1782792000000,"reportTimeType":"post","actualEps":1.22},{"market":"US","date":"2026-03-30","symbol":"PRGS","fiscalQuarterEnding":"2026/02","expectedEps":1.18,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"post","actualEps":1.26},{"market":"US","date":"2026-01-20","symbol":"PRGS","fiscalQuarterEnding":"2025/11","expectedEps":1.02,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1768885200000,"reportTimeType":"post","actualEps":1.07},{"market":"US","date":"2025-09-29","symbol":"PRGS","fiscalQuarterEnding":"2025/08","expectedEps":1.02,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1759118400000,"reportTimeType":"post","actualEps":1.19}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PRGS\",market:\"US\",,,undefined,":[{"executeDate":"2016-11-29","recordDate":"2016-12-01","paymentDate":"2016-12-15","value":0.125,"currency":"USD"},{"executeDate":"2017-02-27","recordDate":"2017-03-01","paymentDate":"2017-03-15","value":0.125,"currency":"USD"},{"executeDate":"2017-05-30","recordDate":"2017-06-01","paymentDate":"2017-06-15","value":0.125,"currency":"USD"},{"executeDate":"2017-08-30","recordDate":"2017-09-01","paymentDate":"2017-09-15","value":0.125,"currency":"USD"},{"executeDate":"2017-11-30","recordDate":"2017-12-01","paymentDate":"2017-12-15","value":0.14,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PRGS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.8333,"buy":0.1667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.8333,"analysts":6,"updateTime":1787544000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PRGS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PRGS","date":"2026-08-21","current":20.971793,"percent":0.090984,"low":12.420616,"twenty":24.107426,"median":28.609704,"eighty":34.925136,"high":49.027418,"avg":29.22959,"sd":7.278506,"marketCap":1772169223},"quantilePoints":[{"date":"2021-08-27","current":27.879225,"twenty":25.810602,"median":34.900097,"eighty":65.760971,"marketCap":2067411795},{"date":"2021-09-03","current":27.584207,"twenty":25.810602,"median":34.802675,"eighty":65.760971,"marketCap":2045534422},{"date":"2021-09-10","current":26.764056,"twenty":25.810602,"median":34.696848,"eighty":65.760971,"marketCap":1984715323},{"date":"2021-09-17","current":27.194782,"twenty":25.810602,"median":34.619571,"eighty":65.760971,"marketCap":2016656289},{"date":"2021-09-24","current":28.628884,"twenty":25.806064,"median":34.555296,"eighty":65.760971,"marketCap":2323377065},{"date":"2021-10-01","current":26.860471,"twenty":25.806064,"median":34.507658,"eighty":65.760971,"marketCap":2179861495},{"date":"2021-10-08","current":26.514593,"twenty":25.806064,"median":34.438441,"eighty":65.661871,"marketCap":2151791814},{"date":"2021-10-15","current":27.108849,"twenty":25.806064,"median":34.354044,"eighty":64.275527,"marketCap":2200018607},{"date":"2021-10-22","current":27.632874,"twenty":25.806064,"median":34.300826,"eighty":62.694875,"marketCap":2242545869},{"date":"2021-10-29","current":27.773334,"twenty":25.806064,"median":34.167974,"eighty":59.444271,"marketCap":2253944929},{"date":"2021-11-05","current":28.221727,"twenty":25.806064,"median":34.108443,"eighty":55.556032,"marketCap":2290334237},{"date":"2021-11-12","current":28.210922,"twenty":25.806064,"median":34.029261,"eighty":52.35114,"marketCap":2289457386},{"date":"2021-11-19","current":28.351382,"twenty":25.806064,"median":33.965855,"eighty":50.642427,"marketCap":2300856446},{"date":"2021-11-26","current":26.357926,"twenty":25.806064,"median":33.911696,"eighty":49.251547,"marketCap":2139077477},{"date":"2021-12-03","current":26.411949,"twenty":25.806064,"median":33.849872,"eighty":48.780144,"marketCap":2143461731},{"date":"2021-12-10","current":26.179649,"twenty":25.806064,"median":33.813941,"eighty":48.070929,"marketCap":2124609439},{"date":"2021-12-17","current":25.277462,"twenty":25.752738,"median":33.769227,"eighty":47.820523,"marketCap":2051392399},{"date":"2021-12-23","current":26.104017,"twenty":25.69374,"median":33.736473,"eighty":47.644524,"marketCap":2118471484},{"date":"2021-12-31","current":26.077005,"twenty":25.69374,"median":33.657495,"eighty":47.479592,"marketCap":2116279357},{"date":"2022-01-07","current":24.650792,"twenty":25.656299,"median":33.617593,"eighty":47.158987,"marketCap":2000535054},{"date":"2022-01-14","current":24.80746,"twenty":25.582638,"median":33.544867,"eighty":47.084303,"marketCap":2013249390},{"date":"2022-01-21","current":24.878768,"twenty":25.526483,"median":33.473699,"eighty":46.995008,"marketCap":1950992985},{"date":"2022-01-28","current":25.735827,"twenty":25.462515,"median":33.407153,"eighty":46.923028,"marketCap":2018203519},{"date":"2022-02-04","current":25.273844,"twenty":25.430444,"median":33.338006,"eighty":46.773605,"marketCap":1981974822},{"date":"2022-02-11","current":25.352719,"twenty":25.421495,"median":33.298868,"eighty":46.720696,"marketCap":1988160210},{"date":"2022-02-18","current":24.778057,"twenty":25.381666,"median":33.216837,"eighty":46.59349,"marketCap":1943095245},{"date":"2022-02-25","current":24.907638,"twenty":25.361663,"median":33.172459,"eighty":46.355101,"marketCap":1953256952},{"date":"2022-03-04","current":24.947075,"twenty":25.340579,"median":33.111518,"eighty":46.188231,"marketCap":1956349646},{"date":"2022-03-11","current":24.704816,"twenty":25.313281,"median":33.064287,"eighty":45.995999,"marketCap":1937351671},{"date":"2022-03-18","current":25.533005,"twenty":25.28899,"median":32.995762,"eighty":45.764886,"marketCap":2002298238},{"date":"2022-03-25","current":25.02595,"twenty":25.272503,"median":32.935787,"eighty":45.516351,"marketCap":1962535033},{"date":"2022-04-01","current":26.040081,"twenty":25.265285,"median":32.863231,"eighty":45.402658,"marketCap":2080941019},{"date":"2022-04-08","current":25.133378,"twenty":25.253427,"median":32.75558,"eighty":45.360936,"marketCap":2008483625},{"date":"2022-04-14","current":26.003554,"twenty":25.265285,"median":32.75558,"eighty":45.360936,"marketCap":2078022024},{"date":"2022-04-22","current":26.518368,"twenty":25.293008,"median":32.75558,"eighty":45.360936,"marketCap":2119162309},{"date":"2022-04-29","current":26.277391,"twenty":25.313571,"median":32.75558,"eighty":45.360936,"marketCap":2099905154},{"date":"2022-05-06","current":25.609229,"twenty":25.344214,"median":32.75558,"eighty":45.360936,"marketCap":2046510317},{"date":"2022-05-13","current":25.773531,"twenty":25.351444,"median":32.75558,"eighty":45.360936,"marketCap":2059640195},{"date":"2022-05-20","current":25.576369,"twenty":25.379417,"median":32.75558,"eighty":45.360936,"marketCap":2043884342},{"date":"2022-05-27","current":26.48003,"twenty":25.421495,"median":32.75558,"eighty":45.360936,"marketCap":2116098671},{"date":"2022-06-03","current":27.328925,"twenty":25.446428,"median":32.75558,"eighty":45.360936,"marketCap":2183936374},{"date":"2022-06-10","current":26.556705,"twenty":25.469327,"median":32.75558,"eighty":45.360936,"marketCap":2122225947},{"date":"2022-06-17","current":25.702334,"twenty":25.521737,"median":32.75558,"eighty":45.360936,"marketCap":2053950581},{"date":"2022-06-24","current":28.238063,"twenty":25.545817,"median":32.763448,"eighty":45.362316,"marketCap":2256588365},{"date":"2022-07-01","current":20.643943,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":1970794687},{"date":"2022-07-08","current":20.67145,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":1973420663},{"date":"2022-07-15","current":20.318369,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":1939713433},{"date":"2022-07-22","current":20.919316,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":1997083403},{"date":"2022-07-29","current":21.379131,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":2040980122},{"date":"2022-08-05","current":21.552131,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":2057495719},{"date":"2022-08-12","current":22.571919,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":2154850818},{"date":"2022-08-19","current":23.054497,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":2200920642},{"date":"2022-08-26","current":22.134867,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":2113127204},{"date":"2022-09-02","current":21.074105,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":2011860516},{"date":"2022-09-09","current":21.465631,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":2049237920},{"date":"2022-09-16","current":19.52166,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":1863654762},{"date":"2022-09-23","current":19.15745,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":1828885083},{"date":"2022-09-30","current":21.432108,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":1849312269},{"date":"2022-10-07","current":22.610748,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":1951013579},{"date":"2022-10-14","current":22.847858,"twenty":25.528498,"median":32.739844,"eighty":45.260277,"marketCap":1971473109},{"date":"2022-10-21","current":23.929207,"twenty":25.484412,"median":32.683737,"eighty":45.157758,"marketCap":2064779470},{"date":"2022-10-28","current":25.269681,"twenty":25.455327,"median":32.587399,"eighty":44.991293,"marketCap":2180444959},{"date":"2022-11-04","current":24.706582,"twenty":25.426459,"median":32.517016,"eighty":44.88775,"marketCap":2131856854},{"date":"2022-11-11","current":25.847729,"twenty":25.399985,"median":32.471829,"eighty":44.796127,"marketCap":2230323014},{"date":"2022-11-18","current":25.713184,"twenty":25.399985,"median":32.351753,"eighty":44.671865,"marketCap":2218713466},{"date":"2022-11-25","current":26.485576,"twenty":25.399985,"median":32.195223,"eighty":44.624386,"marketCap":2285360867},{"date":"2022-12-02","current":26.86928,"twenty":25.399985,"median":32.135964,"eighty":44.585713,"marketCap":2318469576},{"date":"2022-12-09","current":25.763015,"twenty":25.399985,"median":32.055305,"eighty":44.481345,"marketCap":2223013299},{"date":"2022-12-16","current":25.399243,"twenty":25.394155,"median":31.936775,"eighty":44.370506,"marketCap":2191624523},{"date":"2022-12-23","current":25.145102,"twenty":25.36657,"median":31.878678,"eighty":44.308273,"marketCap":2169695378},{"date":"2022-12-30","current":25.140118,"twenty":25.343523,"median":31.795682,"eighty":44.250723,"marketCap":2169265395},{"date":"2023-01-06","current":25.94241,"twenty":25.36657,"median":31.795682,"eighty":44.250723,"marketCap":2238492695},{"date":"2023-01-13","current":26.789549,"twenty":25.378239,"median":31.704386,"eighty":44.185759,"marketCap":2311589844},{"date":"2023-01-20","current":23.496228,"twenty":25.35017,"median":31.62255,"eighty":44.110351,"marketCap":2233762879},{"date":"2023-01-27","current":23.894239,"twenty":25.313644,"median":31.417975,"eighty":43.987218,"marketCap":2271601404},{"date":"2023-02-03","current":25.837838,"twenty":25.313281,"median":31.306166,"eighty":43.820895,"marketCap":2456377414},{"date":"2023-02-10","current":26.052127,"twenty":25.313281,"median":31.197684,"eighty":43.702315,"marketCap":2476749699},{"date":"2023-02-17","current":26.357604,"twenty":25.313281,"median":30.990623,"eighty":43.430265,"marketCap":2505791041},{"date":"2023-02-24","current":26.020212,"twenty":25.313281,"median":30.741305,"eighty":43.286901,"marketCap":2473715529},{"date":"2023-03-03","current":26.836336,"twenty":25.313281,"median":30.476049,"eighty":43.140932,"marketCap":2551303592},{"date":"2023-03-10","current":25.623548,"twenty":25.313281,"median":30.418706,"eighty":42.95958,"marketCap":2436005129},{"date":"2023-03-17","current":26.248179,"twenty":25.313281,"median":29.502053,"eighty":42.746934,"marketCap":2495388172},{"date":"2023-03-24","current":26.325688,"twenty":25.313281,"median":28.729545,"eighty":42.638559,"marketCap":2502756871},{"date":"2023-03-31","current":25.335355,"twenty":25.305985,"median":28.529626,"eighty":42.617599,"marketCap":2490186738},{"date":"2023-04-06","current":24.00354,"twenty":25.293008,"median":28.43459,"eighty":42.617599,"marketCap":2359283971},{"date":"2023-04-14","current":25.031071,"twenty":25.268664,"median":28.314706,"eighty":42.619802,"marketCap":2460278907},{"date":"2023-04-21","current":24.846014,"twenty":25.235585,"median":28.238063,"eighty":42.619802,"marketCap":2442089906},{"date":"2023-04-28","current":24.211536,"twenty":25.180224,"median":28.073042,"eighty":42.619802,"marketCap":2379727617},{"date":"2023-05-05","current":23.572651,"twenty":25.160136,"median":27.854369,"eighty":42.619802,"marketCap":2316932257},{"date":"2023-05-10","current":23.850235,"twenty":25.151082,"median":27.800346,"eighty":42.619802,"marketCap":2344215758},{"date":"2023-05-18","current":24.964979,"twenty":25.140118,"median":27.716839,"eighty":42.626409,"marketCap":2453782835},{"date":"2023-05-24","current":25.832981,"twenty":25.137422,"median":27.642018,"eighty":42.626409,"marketCap":2539097911},{"date":"2023-06-02","current":26.238343,"twenty":25.133378,"median":27.603517,"eighty":42.626409,"marketCap":2578940484},{"date":"2023-06-06","current":26.357308,"twenty":25.132175,"median":27.596024,"eighty":42.632484,"marketCap":2590633413},{"date":"2023-06-15","current":26.982974,"twenty":25.127361,"median":27.542904,"eighty":42.656785,"marketCap":2652129559},{"date":"2023-06-23","current":25.097162,"twenty":25.118263,"median":27.478473,"eighty":42.660789,"marketCap":2466774979},{"date":"2023-06-30","current":29.244806,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2376696117},{"date":"2023-07-07","current":30.262619,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2459412764},{"date":"2023-07-14","current":31.050782,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2523465968},{"date":"2023-07-21","current":31.002757,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2519563031},{"date":"2023-07-28","current":31.008093,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2519996691},{"date":"2023-08-04","current":32.379471,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2631447241},{"date":"2023-08-11","current":32.005944,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2601091060},{"date":"2023-08-18","current":31.221537,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2537343080},{"date":"2023-08-25","current":32.336782,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2627977963},{"date":"2023-09-01","current":32.464849,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2638385797},{"date":"2023-09-08","current":31.130823,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2529970864},{"date":"2023-09-15","current":30.735952,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2497880044},{"date":"2023-09-22","current":30.042258,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2441504279},{"date":"2023-09-29","current":29.446031,"twenty":25.112561,"median":27.439397,"eighty":42.674891,"marketCap":2313574659},{"date":"2023-10-06","current":28.513251,"twenty":25.112561,"median":27.514023,"eighty":42.674891,"marketCap":2240286165},{"date":"2023-10-13","current":29.293079,"twenty":25.112561,"median":27.556797,"eighty":42.674891,"marketCap":2301557229},{"date":"2023-10-20","current":28.472452,"twenty":25.111856,"median":27.600926,"eighty":42.680606,"marketCap":2237080517},{"date":"2023-10-27","current":28.051048,"twenty":25.125541,"median":27.632874,"eighty":42.697564,"marketCap":2203970854},{"date":"2023-11-03","current":27.540928,"twenty":25.141891,"median":27.736377,"eighty":42.697564,"marketCap":2163890735},{"date":"2023-11-10","current":28.716422,"twenty":25.141891,"median":27.838262,"eighty":42.697564,"marketCap":2256249269},{"date":"2023-11-17","current":29.675669,"twenty":25.141891,"median":28.023324,"eighty":42.697564,"marketCap":2331617317},{"date":"2023-11-24","current":29.659035,"twenty":25.141891,"median":28.13422,"eighty":42.697564,"marketCap":2330310357},{"date":"2023-12-01","current":29.864192,"twenty":25.141891,"median":28.238063,"eighty":42.697564,"marketCap":2346429535},{"date":"2023-12-08","current":29.437243,"twenty":25.141891,"median":28.27575,"eighty":42.697564,"marketCap":2312884219},{"date":"2023-12-15","current":30.795715,"twenty":25.141891,"median":28.351382,"eighty":42.697564,"marketCap":2419619316},{"date":"2023-12-22","current":30.485207,"twenty":25.141891,"median":28.421613,"eighty":42.697564,"marketCap":2395222723},{"date":"2023-12-29","current":30.180244,"twenty":25.141448,"median":28.480769,"eighty":42.70309,"marketCap":2371261782},{"date":"2024-01-05","current":29.049109,"twenty":25.141004,"median":28.513251,"eighty":42.708617,"marketCap":2282388476},{"date":"2024-01-12","current":29.570318,"twenty":25.141004,"median":28.628884,"eighty":42.708617,"marketCap":2323339902},{"date":"2024-01-19","current":35.890194,"twenty":25.140561,"median":28.764903,"eighty":42.714143,"marketCap":2519383959},{"date":"2024-01-26","current":36.579077,"twenty":25.141004,"median":28.800261,"eighty":42.708617,"marketCap":2567741493},{"date":"2024-02-02","current":36.212094,"twenty":25.141004,"median":28.800261,"eighty":42.708617,"marketCap":2541980333},{"date":"2024-02-09","current":35.868288,"twenty":25.141004,"median":28.800261,"eighty":42.708617,"marketCap":2517846220},{"date":"2024-02-16","current":35.224434,"twenty":25.141004,"median":28.800261,"eighty":42.708617,"marketCap":2472649608},{"date":"2024-02-23","current":34.255528,"twenty":25.141004,"median":28.800261,"eighty":42.708617,"marketCap":2404635288},{"date":"2024-03-01","current":33.355383,"twenty":25.141448,"median":28.809468,"eighty":42.70309,"marketCap":2341447792},{"date":"2024-03-08","current":33.699188,"twenty":25.141448,"median":28.809468,"eighty":42.70309,"marketCap":2365581905},{"date":"2024-03-15","current":33.09284,"twenty":25.141448,"median":28.809468,"eighty":42.70309,"marketCap":2323018105},{"date":"2024-03-22","current":33.061585,"twenty":25.141448,"median":28.809468,"eighty":42.70309,"marketCap":2320824095},{"date":"2024-03-28","current":33.391389,"twenty":25.141448,"median":28.809468,"eighty":42.70309,"marketCap":2309415241},{"date":"2024-04-05","current":32.395294,"twenty":25.141004,"median":28.800261,"eighty":42.622004,"marketCap":2240523318},{"date":"2024-04-12","current":32.287651,"twenty":25.141004,"median":28.800261,"eighty":42.404436,"marketCap":2233078503},{"date":"2024-04-19","current":31.362825,"twenty":25.141004,"median":28.800261,"eighty":42.07362,"marketCap":2169115736},{"date":"2024-04-26","current":31.681515,"twenty":25.141448,"median":28.809468,"eighty":41.925727,"marketCap":2191156960},{"date":"2024-05-03","current":31.519046,"twenty":25.141448,"median":28.809468,"eighty":41.692905,"marketCap":2179920257},{"date":"2024-05-10","current":31.756501,"twenty":25.141448,"median":28.809468,"eighty":41.605205,"marketCap":2196343130},{"date":"2024-05-17","current":32.306397,"twenty":25.141448,"median":28.809468,"eighty":41.374011,"marketCap":2234375046},{"date":"2024-05-24","current":31.606529,"twenty":25.141448,"median":28.809468,"eighty":41.232151,"marketCap":2185970789},{"date":"2024-05-31","current":30.931657,"twenty":25.141448,"median":28.809468,"eighty":40.957916,"marketCap":2139295257},{"date":"2024-06-07","current":31.281591,"twenty":25.141448,"median":28.809468,"eighty":40.957916,"marketCap":2163497385},{"date":"2024-06-14","current":31.256596,"twenty":25.141004,"median":28.800261,"eighty":40.758432,"marketCap":2161768661},{"date":"2024-06-21","current":30.11931,"twenty":25.140561,"median":28.764903,"eighty":39.595792,"marketCap":2083111745},{"date":"2024-06-28","current":31.997666,"twenty":25.140118,"median":28.716422,"eighty":37.803838,"marketCap":2344148984},{"date":"2024-07-05","current":32.109752,"twenty":25.140118,"median":28.716422,"eighty":37.303436,"marketCap":2352360420},{"date":"2024-07-12","current":32.079419,"twenty":25.140118,"median":28.716422,"eighty":37.176219,"marketCap":2350138272},{"date":"2024-07-15","current":32.19036,"twenty":25.140118,"median":28.716422,"eighty":37.131908,"marketCap":2358265798},{"date":"2024-08-02","current":33.469099,"twenty":25.127361,"median":28.480769,"eighty":36.603511,"marketCap":2451946228},{"date":"2024-08-09","current":32.774259,"twenty":25.127361,"median":28.480769,"eighty":36.277577,"marketCap":2401042250},{"date":"2024-08-16","current":33.101243,"twenty":25.127361,"median":28.480769,"eighty":35.980806,"marketCap":2424997063},{"date":"2024-08-23","current":33.107082,"twenty":25.127361,"median":28.480769,"eighty":35.868288,"marketCap":2425424828},{"date":"2024-08-30","current":34.017965,"twenty":25.127361,"median":28.480769,"eighty":35.718264,"marketCap":2492156093},{"date":"2024-09-06","current":33.679303,"twenty":25.127361,"median":28.480769,"eighty":35.538198,"marketCap":2467345751},{"date":"2024-09-13","current":33.439905,"twenty":25.127361,"median":28.480769,"eighty":35.480584,"marketCap":2449807406},{"date":"2024-09-20","current":33.673464,"twenty":25.127361,"median":28.480769,"eighty":35.352107,"marketCap":2466917986},{"date":"2024-09-27","current":34.086142,"twenty":25.127361,"median":28.480769,"eighty":35.269333,"marketCap":2816401599},{"date":"2024-10-04","current":33.552899,"twenty":25.127361,"median":28.480769,"eighty":35.095806,"marketCap":2772341854},{"date":"2024-10-11","current":33.866649,"twenty":25.127361,"median":28.480769,"eighty":35.005903,"marketCap":2798265730},{"date":"2024-10-18","current":34.443036,"twenty":25.127361,"median":28.480769,"eighty":34.866036,"marketCap":2845890308},{"date":"2024-10-25","current":33.814722,"twenty":25.127361,"median":28.480769,"eighty":34.668094,"marketCap":2793975228},{"date":"2024-10-31","current":33.586244,"twenty":25.127361,"median":28.480769,"eighty":34.593624,"marketCap":2775097017},{"date":"2024-11-08","current":35.003845,"twenty":25.124683,"median":28.472452,"eighty":34.474261,"marketCap":2892227735},{"date":"2024-11-15","current":34.920763,"twenty":25.124683,"median":28.472452,"eighty":34.474261,"marketCap":2885362931},{"date":"2024-11-22","current":35.689279,"twenty":25.124683,"median":28.472452,"eighty":34.42807,"marketCap":2948862368},{"date":"2024-11-29","current":35.523113,"twenty":25.124683,"median":28.472452,"eighty":34.42807,"marketCap":2935132760},{"date":"2024-12-06","current":35.647738,"twenty":25.124683,"median":28.472452,"eighty":34.42807,"marketCap":2945429966},{"date":"2024-12-13","current":36.15662,"twenty":25.124683,"median":28.472452,"eighty":34.42807,"marketCap":2987476890},{"date":"2024-12-20","current":34.230136,"twenty":25.124683,"median":28.472452,"eighty":34.396717,"marketCap":2828299248},{"date":"2024-12-27","current":34.476789,"twenty":25.124683,"median":28.472452,"eighty":34.396717,"marketCap":2848679134},{"date":"2025-01-03","current":33.601822,"twenty":25.124683,"median":28.472452,"eighty":34.355231,"marketCap":2776384167},{"date":"2025-01-10","current":32.885233,"twenty":25.122004,"median":28.462046,"eighty":34.30718,"marketCap":2717175233},{"date":"2025-01-17","current":33.087747,"twenty":25.122004,"median":28.462046,"eighty":34.198287,"marketCap":2733908193},{"date":"2025-01-24","current":34.296248,"twenty":25.122004,"median":28.462046,"eighty":34.179804,"marketCap":2347166594},{"date":"2025-01-31","current":36.121325,"twenty":25.122004,"median":28.462046,"eighty":34.169311,"marketCap":2472071247},{"date":"2025-02-07","current":36.260741,"twenty":25.122004,"median":28.462046,"eighty":34.169311,"marketCap":2481612574},{"date":"2025-02-14","current":36.697999,"twenty":25.122004,"median":28.462046,"eighty":34.169311,"marketCap":2511537647},{"date":"2025-02-21","current":35.842494,"twenty":25.122004,"median":28.462046,"eighty":34.169311,"marketCap":2452988591},{"date":"2025-02-28","current":34.416652,"twenty":25.122004,"median":28.462046,"eighty":34.169311,"marketCap":2355406832},{"date":"2025-03-07","current":35.240472,"twenty":25.119326,"median":28.45164,"eighty":34.160032,"marketCap":2411787404},{"date":"2025-03-14","current":34.023753,"twenty":25.119326,"median":28.45164,"eighty":34.155864,"marketCap":2328517635},{"date":"2025-03-21","current":34.359618,"twenty":25.119326,"median":28.45164,"eighty":34.155864,"marketCap":2351503561},{"date":"2025-03-28","current":33.646187,"twenty":25.119326,"median":28.45164,"eighty":34.152584,"marketCap":2302677715},{"date":"2025-04-04","current":43.969996,"twenty":25.119326,"median":28.45164,"eighty":34.131939,"marketCap":2495077450},{"date":"2025-04-11","current":43.098027,"twenty":25.122004,"median":28.462046,"eighty":34.151143,"marketCap":2445597555},{"date":"2025-04-17","current":42.514187,"twenty":25.122004,"median":28.462046,"eighty":34.151143,"marketCap":2412467539},{"date":"2025-04-25","current":44.788889,"twenty":25.119326,"median":28.45164,"eighty":34.131939,"marketCap":2541545524},{"date":"2025-05-02","current":45.592617,"twenty":25.119326,"median":28.45164,"eighty":34.131939,"marketCap":2587153079},{"date":"2025-05-09","current":46.828539,"twenty":25.119326,"median":28.45164,"eighty":34.131939,"marketCap":2657285451},{"date":"2025-05-16","current":47.48062,"twenty":25.119326,"median":28.45164,"eighty":34.131939,"marketCap":2694287806},{"date":"2025-05-23","current":46.464587,"twenty":25.119326,"median":28.45164,"eighty":34.131939,"marketCap":2636632973},{"date":"2025-05-30","current":46.305358,"twenty":25.119326,"median":28.45164,"eighty":34.131939,"marketCap":2627597514},{"date":"2025-06-06","current":48.216108,"twenty":25.119326,"median":28.45164,"eighty":34.131939,"marketCap":2736023022},{"date":"2025-06-13","current":47.950726,"twenty":25.119326,"median":28.45164,"eighty":34.131939,"marketCap":2720963923},{"date":"2025-06-20","current":47.776332,"twenty":25.116647,"median":28.436627,"eighty":34.10319,"marketCap":2711067944},{"date":"2025-06-27","current":48.337425,"twenty":25.116647,"median":28.436627,"eighty":34.10319,"marketCap":2742907181},{"date":"2025-07-03","current":40.760766,"twenty":25.116647,"median":28.436627,"eighty":34.10319,"marketCap":2347249494},{"date":"2025-07-11","current":37.908636,"twenty":25.116647,"median":28.436627,"eighty":34.10319,"marketCap":2183006692},{"date":"2025-07-18","current":36.467598,"twenty":25.116647,"median":28.436627,"eighty":34.154024,"marketCap":2100023124},{"date":"2025-07-25","current":37.40708,"twenty":25.116647,"median":28.436627,"eighty":34.161332,"marketCap":2154124099},{"date":"2025-08-01","current":35.992243,"twenty":25.116647,"median":28.436627,"eighty":34.239534,"marketCap":2072649323},{"date":"2025-08-08","current":32.653529,"twenty":25.116647,"median":28.436627,"eighty":34.17599,"marketCap":1880386096},{"date":"2025-08-15","current":33.649154,"twenty":25.116647,"median":28.436627,"eighty":34.140101,"marketCap":1937720197},{"date":"2025-08-22","current":33.469492,"twenty":25.116647,"median":28.436627,"eighty":34.082,"marketCap":1927374194},{"date":"2025-08-29","current":34.667238,"twenty":25.116647,"median":28.436627,"eighty":34.062315,"marketCap":1996347549},{"date":"2025-09-05","current":33.072739,"twenty":25.113969,"median":28.421613,"eighty":34.017965,"marketCap":1904526770},{"date":"2025-09-12","current":32.196888,"twenty":25.116647,"median":28.436627,"eighty":33.971212,"marketCap":1854090004},{"date":"2025-09-19","current":32.526268,"twenty":25.116647,"median":28.436627,"eighty":33.958407,"marketCap":1873057677},{"date":"2025-09-26","current":30.841939,"twenty":25.116647,"median":28.436627,"eighty":33.949365,"marketCap":1776063896},{"date":"2025-10-03","current":40.949393,"twenty":25.116647,"median":28.436627,"eighty":33.958407,"marketCap":1987478781},{"date":"2025-10-10","current":41.028958,"twenty":25.116647,"median":28.436627,"eighty":34.014704,"marketCap":1991340462},{"date":"2025-10-17","current":39.667514,"twenty":25.116647,"median":28.436627,"eighty":34.101864,"marketCap":1925262800},{"date":"2025-10-24","current":39.844325,"twenty":25.116647,"median":28.436627,"eighty":34.180279,"marketCap":1933844315},{"date":"2025-10-31","current":36.979989,"twenty":25.116647,"median":28.447032,"eighty":34.253533,"marketCap":1794823778},{"date":"2025-11-07","current":37.094916,"twenty":25.116647,"median":28.447032,"eighty":34.358647,"marketCap":1800401763},{"date":"2025-11-14","current":37.395495,"twenty":25.116647,"median":28.447032,"eighty":34.405649,"marketCap":1814990337},{"date":"2025-11-21","current":35.04391,"twenty":25.116647,"median":28.447032,"eighty":34.468224,"marketCap":1700856193},{"date":"2025-11-28","current":36.608686,"twenty":25.116647,"median":28.447032,"eighty":34.512555,"marketCap":1776802597},{"date":"2025-12-05","current":38.306071,"twenty":25.116647,"median":28.447032,"eighty":34.591182,"marketCap":1859185138},{"date":"2025-12-12","current":39.870847,"twenty":25.116647,"median":28.447032,"eighty":34.666016,"marketCap":1935131542},{"date":"2025-12-19","current":38.394476,"twenty":25.116647,"median":28.447032,"eighty":34.828534,"marketCap":1863475895},{"date":"2025-12-26","current":37.864043,"twenty":25.116647,"median":28.447032,"eighty":34.873375,"marketCap":1837731351},{"date":"2026-01-02","current":37.978971,"twenty":25.116647,"median":28.447032,"eighty":34.873375,"marketCap":1843309336},{"date":"2026-01-09","current":37.201003,"twenty":25.116647,"median":28.447032,"eighty":34.873375,"marketCap":1805550671},{"date":"2026-01-16","current":36.1755,"twenty":25.128564,"median":28.501168,"eighty":34.920067,"marketCap":1755777887},{"date":"2026-01-23","current":24.617593,"twenty":25.134726,"median":28.551887,"eighty":34.920763,"marketCap":1800358452},{"date":"2026-01-30","current":22.867009,"twenty":25.134726,"median":28.551887,"eighty":34.920763,"marketCap":1672332962},{"date":"2026-02-06","current":23.845954,"twenty":25.134726,"median":28.551887,"eighty":34.920763,"marketCap":1743926163},{"date":"2026-02-13","current":20.534816,"twenty":25.140118,"median":28.551887,"eighty":34.920763,"marketCap":1501772687},{"date":"2026-02-20","current":20.972462,"twenty":25.140118,"median":28.551887,"eighty":34.920763,"marketCap":1533779060},{"date":"2026-02-27","current":24.237532,"twenty":25.134726,"median":28.551887,"eighty":34.920763,"marketCap":1772563444},{"date":"2026-03-06","current":22.867009,"twenty":25.134726,"median":28.551887,"eighty":34.920763,"marketCap":1672332962},{"date":"2026-03-13","current":20.552091,"twenty":25.116647,"median":28.551887,"eighty":34.920763,"marketCap":1503036097},{"date":"2026-03-20","current":18.323551,"twenty":25.100523,"median":28.551887,"eighty":34.920763,"marketCap":1340056279},{"date":"2026-03-27","current":16.797548,"twenty":25.097162,"median":28.551887,"eighty":34.920763,"marketCap":1228455112},{"date":"2026-04-02","current":12.420616,"twenty":25.094279,"median":28.551887,"eighty":34.920763,"marketCap":1055752324},{"date":"2026-04-10","current":13.574065,"twenty":25.076468,"median":28.551887,"eighty":34.920763,"marketCap":1153795486},{"date":"2026-04-17","current":14.762166,"twenty":25.026551,"median":28.551887,"eighty":34.920763,"marketCap":1254784150},{"date":"2026-04-24","current":13.593866,"twenty":25.0069,"median":28.551887,"eighty":34.920763,"marketCap":1155478630},{"date":"2026-05-01","current":13.786933,"twenty":24.967613,"median":28.551887,"eighty":34.920763,"marketCap":1171889288},{"date":"2026-05-08","current":14.539397,"twenty":24.959976,"median":28.551887,"eighty":34.920763,"marketCap":1235848775},{"date":"2026-05-15","current":13.267138,"twenty":24.95249,"median":28.551887,"eighty":34.920763,"marketCap":1127706748},{"date":"2026-05-22","current":14.316628,"twenty":24.947131,"median":28.551887,"eighty":34.920763,"marketCap":1216913401},{"date":"2026-05-29","current":15.118597,"twenty":24.914138,"median":28.590523,"eighty":34.920763,"marketCap":1285080749},{"date":"2026-06-05","current":15.61859,"twenty":24.871457,"median":28.551887,"eighty":34.920763,"marketCap":1327580145},{"date":"2026-06-12","current":15.638392,"twenty":24.83672,"median":28.551887,"eighty":34.920763,"marketCap":1329263289},{"date":"2026-06-18","current":14.890878,"twenty":24.760249,"median":28.551887,"eighty":34.920763,"marketCap":1265724588},{"date":"2026-06-26","current":14.757216,"twenty":24.709425,"median":28.590523,"eighty":34.920763,"marketCap":1254363364},{"date":"2026-07-02","current":18.036777,"twenty":24.704816,"median":28.590523,"eighty":34.920763,"marketCap":1606066808},{"date":"2026-07-10","current":17.732787,"twenty":24.650792,"median":28.590523,"eighty":34.920763,"marketCap":1578998267},{"date":"2026-07-17","current":18.584882,"twenty":24.563968,"median":28.590523,"eighty":34.920763,"marketCap":1654872209},{"date":"2026-07-24","current":17.005052,"twenty":24.433321,"median":28.590523,"eighty":34.920763,"marketCap":1514197818},{"date":"2026-07-31","current":18.580276,"twenty":24.379178,"median":28.609704,"eighty":34.925136,"marketCap":1654462080},{"date":"2026-08-07","current":19.257346,"twenty":24.232333,"median":28.609704,"eighty":34.925136,"marketCap":1714751105},{"date":"2026-08-14","current":20.602274,"twenty":24.182374,"median":28.609704,"eighty":34.925136,"marketCap":1834508895},{"date":"2026-08-21","current":19.902174,"twenty":24.107426,"median":28.609704,"eighty":34.925136,"marketCap":1772169223}],"updateTime":1787609588367},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PRGS\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658948041","title":"Press Release: BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2658948041","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658948041?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:05","pubTimestamp":1786478700,"startTime":"0","endTime":"0","summary":"-- Continued to advance monotherapy and combination cohorts for all clinical. -- Initiated dosing of BBO-11818 in combination with cetuximab and after the. end of the quarter, initiated dosing of BBO-11818 in combination with. -- Presented preclinical data at AACR highlighting the potency and activity. of BBO-11818 in KRAS mutant tumor models and the efficacy of BBO-10203 in. combination with tucatinib and trastuzumab in HER2amp models. -- Initiated BBO-8520 plus BBO-10203 combination in patients with G12C. NSCLC.BBO-11818: An orally bioavailable small molecule pan-KRAS inhibitor that targets mutant KRAS in both the ON and OFF states.-- Continued to enroll BBO-11818 monotherapy across multiple dose levels.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","LU0266512127.USD","BK4213","BK4139","LU0456854461.SGD","BBOT","PRGS","CRC","LU2065732104.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658948500","title":"Press Release: Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658948500","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658948500?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:02","pubTimestamp":1786478520,"startTime":"0","endTime":"0","summary":"-- Kyverna has initiated its rolling BLA, submitted the Chemistry,Manufacturing and Controls  module and is on track to. complete its submission in the fourth quarter of 2026.-- The Company plans to seek priority review, under the Regenerative. -- Kyverna continues to advance activities to enable a successful. rare disease launch in SPS upon approval. These efforts include. hiring key commercial leadership roles, commercial site activation,a commercial supply agreement, payer and patient advocacy. -- The Company plans to report 12-month topline data from KYSA-8 in. -- Enrollment Ongoing in KYSA-6 Registrational Trial for gMG:. -- Kyverna continues to advance its Phase 3 gMG trial and expects to. complete enrollment by mid-2027. The Company anticipates sharing. longer-term follow-up Phase 2 topline data in Q3 2026.-- Advancing Progressive Multiple Sclerosis  Strategy with RMAT. Designation Granted for Miv-cel for Treatment of No","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0971096721.USD","LU2237443549.SGD","LU0882574139.USD","KYTX","BK4139","IE00BKVL7J92.USD","LU0149725797.USD","PRGS","IE00B1BXHZ80.USD","IE00BHPRN162.USD","LU2746668974.SGD","BK4006","IE00BZ1G4Q59.USD","LU2065732104.USD","LU2237443382.USD","IE00BFXG1179.USD","LU2237443622.USD","LU2237443978.SGD","LU2746668461.USD","CMC","BK4097","LU1363072403.SGD","LU2237443895.HKD","LU2237443465.HKD","LU0267386448.USD","LU0170899867.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658221910","title":"Matt Phipps Initiates Buy on Upstream Bio, Citing Favorable FDA Progress and Best-in-Class Potential for Verekitug","url":"https://stock-news.laohu8.com/highlight/detail?id=2658221910","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658221910?lang=en_us&edition=fundamental","pubTime":"2026-08-12 03:05","pubTimestamp":1786475121,"startTime":"0","endTime":"0","summary":"William Blair analyst Matt Phipps has maintained their bullish stance on UPB stock, giving a Buy rating today. Matt Phipps has given his Buy rating...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/matt-phipps-initiates-buy-on-upstream-bio-citing-favorable-fda-progress-and-best-in-class-potential-for-verekitug-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/matt-phipps-initiates-buy-on-upstream-bio-citing-favorable-fda-progress-and-best-in-class-potential-for-verekitug-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4097","BK4588","BK4139","LU2065732104.USD","UPB","PRGS","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658910679","title":"Analyst Reaffirms Buy on Shattuck Labs, Maintains $17 Price Target on TL1A Pipeline Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2658910679","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658910679?lang=en_us&edition=fundamental","pubTime":"2026-08-12 02:45","pubTimestamp":1786473925,"startTime":"0","endTime":"0","summary":"Joseph Stringer, an analyst from Needham, maintained the Buy rating on Shattuck Labs. The associated price target remains the same with $17.00. Jos...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-reaffirms-buy-on-shattuck-labs-maintains-17-price-target-on-tl1a-pipeline-progress-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-reaffirms-buy-on-shattuck-labs-maintains-17-price-target-on-tl1a-pipeline-progress-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["STTK","PRGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658917818","title":"Sagimet Making 'Good Progress' in Bringing Denifanstat to US Patients, Wedbush Securities Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658917818","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658917818?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:54","pubTimestamp":1786470873,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences  is making \"good progress\" in advancing denifanstat as a treatment for moderate to severe acne for the US market, Wedbush Securities said in a note Tuesday.The investment firm said positive data from studies conducted in China suggest limited clinical risk for the experimental therapy, which is expected to enter phase 3 testing in H2 after regulatory clearance.The company expects fast patient enrollment in the phase 3 study, with topline data possible by the end of 2027 or in early 2028, according to the note.Wedbush said Sagimet ended Q2 with $257.6 million in cash after raising $175 million in April, with its cash runway expected to extend through 2028 and beyond the anticipated denifanstat phase 3 readout.The firm said recent investor discussions reinforced the view that Sagimet remains \"deeply undervalued\" and continues to offer significant upside despite recent share gains.Wedbush Securities has an outperform rating on Sagimet Biosciences, with a price target o","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","PRGS","BK4097","SGMT","LU2065732104.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658914838","title":"Akeso (SEHK:9926) Could Be 41% Undervalued On Phase II Breast Cancer Trial Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2658914838","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658914838?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:28","pubTimestamp":1786451296,"startTime":"0","endTime":"0","summary":"Akeso (SEHK:9926) has just reached a fresh clinical milestone. The company has dosed the first patient in a Phase II trial of its TROP2/Nectin-4 ADC AK146D1 in combination with ivonescimab for advanced breast cancer.\nSee our latest analysis for Akeso.\nAkeso's latest trial update comes after a mixed period for the stock, with a 7 day share price return of 8.58% and a 30 day share price return of 4.78%, but a 90 day share price return that declined 19.95%. Over longer horizons, total...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-could-be-41-undervalued-on-phase-ii-breast-ca","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-could-be-41-undervalued-on-phase-ii-breast-ca","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0348766576.USD","LU1961090484.USD","BK1161","LU0417516738.SGD","PRGS","LU2399975544.HKD","LU0417516902.SGD","IE00B543WZ88.USD","LU0417516571.SGD","LU0348784397.USD","KURE","LU1720050803.USD","LU2778985437.USD","LU0348827113.USD","09926","LU2476274308.USD","LU0348735423.USD","IE00BPRC5H50.USD","LU1794554557.SGD","LU2065732104.USD","IE00B5MMRT66.SGD","LU2476274720.SGD","LU0540923850.HKD","BK4097","LU0348767384.USD","LU0634319403.HKD","BK1574","LU0348825331.USD","LU0348783233.USD","LU2488822045.USD","LU0561508036.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658997893","title":"Press Release: Veradermics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997893","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658997893?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:30","pubTimestamp":1786447800,"startTime":"0","endTime":"0","summary":"Hair Loss: In July 2026, Veradermics announced positive topline results. from its open-label Phase 2 clinical trial  evaluating","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MANE","PRGS","BK4097","BK4007","BID","LU2065732104.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658972669","title":"Upstream Bio Reports Second Quarter 2026 Financial Results and Highlights Continued Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2658972669","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658972669?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:00","pubTimestamp":1786446000,"startTime":"0","endTime":"0","summary":"– Company rapidly advancing toward Q1 2027 initiation of Phase 3 trials designed to deliver best-in-class efficacy with convenient quarterly dosing in both severe asthma and CRSwNP; End-of-Phase 2 int","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/11/3342576/0/en/upstream-bio-reports-second-quarter-2026-financial-results-and-highlights-continued-progress.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSL","TSLR","07366","TSLP","ATS","09366","TSLO","PRGS","TSLI","09766","TSYY","BK4161","TSLT","TEST","TSLY","ELOL","TSLG","TSDD","TSLS","TSLL","LU2065732104.USD","07766","TESL","TSLW","TSLZ","CRSH","TLA","TSII","TSLQ","BK4097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658991639","title":"Analyst Reiterates Buy on Vera as Trutakna Launch and IgAN Pipeline Progress Support Maintained $90 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2658991639","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658991639?lang=en_us&edition=fundamental","pubTime":"2026-08-11 18:16","pubTimestamp":1786443364,"startTime":"0","endTime":"0","summary":"Rami Katkhuda, an analyst from LifeSci Capital, maintained the Buy rating on Vera Therapeutics. The associated price target remains the same with $...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-vera-as-trutakna-launch-and-igan-pipeline-progress-support-maintained-90-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-vera-as-trutakna-launch-and-igan-pipeline-progress-support-maintained-90-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658299687","title":"Michael Matson Reiterates Buy on IMDX, Citing Regulatory Progress, GraftAssure Platform Expansion, and Solid Cash Runway Ahead of Expected 2026 De Novo Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2658299687","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658299687?lang=en_us&edition=fundamental","pubTime":"2026-08-11 17:15","pubTimestamp":1786439729,"startTime":"0","endTime":"0","summary":"In a report released today, Michael Matson from Needham assigned a Buy rating on Insight Molecular Diagnostics, with a price target of $9.00. Micha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/michael-matson-reiterates-buy-on-imdx-citing-regulatory-progress-graftassure-platform-expansion-and-solid-cash-runway-ahead-of-expected-2026-de-novo-approval-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/michael-matson-reiterates-buy-on-imdx-citing-regulatory-progress-graftassure-platform-expansion-and-solid-cash-runway-ahead-of-expected-2026-de-novo-approval-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4097","MATX","LU2065732104.USD","IMDX","BOAT","BK4021","BK4139","PRGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658995433","title":"Auvelity Momentum and Pipeline Progress Drive Undervalued Upside in Axsome, Supporting Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2658995433","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658995433?lang=en_us&edition=fundamental","pubTime":"2026-08-11 16:56","pubTimestamp":1786438573,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Jason Gerberry has reiterated their bullish stance on AXSM stock, giving a Buy rating yesterday. Jason Gerberry ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/auvelity-momentum-and-pipeline-progress-drive-undervalued-upside-in-axsome-supporting-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/auvelity-momentum-and-pipeline-progress-drive-undervalued-upside-in-axsome-supporting-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658995555","title":"European Midday Briefing: Oil Rises as Hormuz Talks Show Little Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2658995555","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658995555?lang=en_us&edition=fundamental","pubTime":"2026-08-11 16:55","pubTimestamp":1786438500,"startTime":"0","endTime":"0","summary":"MARKET WRAPSStocks:European shares were mostly down Tuesday while oil prices rose on uncertainty over any Middle East peace deal.Brent extended the previous session's gains, trading at around $89 a ba","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DBC","BK4585","PRGS","BK4588","BK4097","EPV","LU2065732104.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658967593","title":"Analyst Reiterates Buy on Warintza De-Risking Progress and Confirms $18 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2658967593","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658967593?lang=en_us&edition=fundamental","pubTime":"2026-08-11 14:35","pubTimestamp":1786430140,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Heiko Ihle from H.C. Wainwright reiterated a Buy rating on Solaris Resources, with a price target of $18.00. Heiko ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-warintza-de-risking-progress-and-confirms-18-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-warintza-de-risking-progress-and-confirms-18-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658966579","title":"Trump: CAP report on National Guard and crime is 'Radical Left SCAM'","url":"https://stock-news.laohu8.com/highlight/detail?id=2658966579","media":"Trump's Truth Social latest posts","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658966579?lang=en_us&edition=fundamental","pubTime":"2026-08-11 10:31","pubTimestamp":1786415504,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"724a78f70d7146f1ab07ec048eae1639","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://trumpstruth.org/statuses/40727","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","BK4117","CAP.AU",".IXIC","PRGS",".DJI","LU2065732104.USD","BK4107",".SPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658747950","title":"DigitalX Updates Investors on Progress of On-Market Share Buy-Back","url":"https://stock-news.laohu8.com/highlight/detail?id=2658747950","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658747950?lang=en_us&edition=fundamental","pubTime":"2026-08-11 07:37","pubTimestamp":1786405042,"startTime":"0","endTime":"0","summary":"DigitalX Limited ( ($AU:DCC) ) has shared an announcement. DigitalX Limited has issued an updated notification regarding its ongoing on-market shar...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/digitalx-updates-investors-on-progress-of-on-market-share-buy-back?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/digitalx-updates-investors-on-progress-of-on-market-share-buy-back?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ISBC","PRGS","LU2065732104.USD","BK4211","BK4097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658957989","title":"First Community Highlights Q2 2026 Growth and Integration Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2658957989","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658957989?lang=en_us&edition=fundamental","pubTime":"2026-08-11 06:16","pubTimestamp":1786400184,"startTime":"0","endTime":"0","summary":"First Community ( ($FCCO) ) has issued an announcement. First Community Corporation used its August 2026 investor presentation to highlight ongoing...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/first-community-highlights-q2-2026-growth-and-integration-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/first-community-highlights-q2-2026-growth-and-integration-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FCCO","PRGS","LU2065732104.USD","BK4211","BK4097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658411956","title":"Press Release: Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658411956","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658411956?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:01","pubTimestamp":1786392060,"startTime":"0","endTime":"0","summary":"-- Septerna's Phase 1 clinical trial of SEP-479, a potent, selective. oral small molecule PTH1R agonist for the treatment of. serum calcium and endogenous serum PTH) in healthy volunteers.-- Based on pharmacokinetic data from the ongoing Phase 1 clinical. trial, the observed elimination half-life of SEP-479 is. approximately three to four days, which the Company anticipates. will support once-daily dosing. To fully characterize steady-state. pharmacokinetics, dosing for the MAD cohorts will be extended to. 14 days. As a result, Septerna expects to report Phase 1 data from. both the SAD and MAD cohorts in the first quarter of 2027.-- During the quarter, the Company presented the first detailed. preclinical characterization of SEP-479 in an oral presentation at. ENDO 2026, highlighting data supporting its potential as a. -- As reported in March 2026, SEP-631, an oral small molecule MRGPRX2","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4599","R","BK4022","BK4097","PRGS","BK4007","GPCR","LU2065732104.USD","SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658955317","title":"Jade Therapeutics: Buy Rating Reiterated as Strong Cash Position and Pipeline Progress Support Unchanged $42 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2658955317","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658955317?lang=en_us&edition=fundamental","pubTime":"2026-08-11 02:15","pubTimestamp":1786385723,"startTime":"0","endTime":"0","summary":"In a report released today, Rami Katkhuda from LifeSci Capital maintained a Buy rating on Jade Biosciences, with a price target of $42.00. Rami Kat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/jade-therapeutics-buy-rating-reiterated-as-strong-cash-position-and-pipeline-progress-support-unchanged-42-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/jade-therapeutics-buy-rating-reiterated-as-strong-cash-position-and-pipeline-progress-support-unchanged-42-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658958640","title":"Buy Rating Reaffirmed on CNM-Au8 ALS Progress, Regulatory Momentum; $31 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2658958640","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658958640?lang=en_us&edition=fundamental","pubTime":"2026-08-11 00:35","pubTimestamp":1786379730,"startTime":"0","endTime":"0","summary":"Joseph Pantginis, an analyst from H.C. Wainwright, maintained the Buy rating on Clene. The associated price target remains the same with $31.00. Jo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-reaffirmed-on-cnm-au8-als-progress-regulatory-momentum-31-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-reaffirmed-on-cnm-au8-als-progress-regulatory-momentum-31-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","CNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658493659","title":"Waton Financial Highlights AlphaSchema Research Progress in Structured AI-Assisted Trading Signal Discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2658493659","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658493659?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:00","pubTimestamp":1786363200,"startTime":"0","endTime":"0","summary":"New arXiv preprint and public core research code reflect Waton’s continued investment in systematic, inspectable and evidence-led quantitative researchHONG KONG, Aug.  10, 2026  (GLOBE NEWSWIRE) -- Wa","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/10/3341768/0/en/waton-financial-highlights-alphaschema-research-progress-in-structured-ai-assisted-trading-signal-discovery.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","VTHR","BK4097","AIPO","LU2065732104.USD","AGIX","QTOC","ARTY","WTF","PRGS","CHAT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}